Juva-019

N/A

Report date: 2024/11/14 10:11:56

NME

Base Information

Drug NameJuva-019

Drug Alias NameN/A

ClassificationSmall molecules

Mechanisms of ActionInterleukin-1 beta modulatorsTumor necrosis factor α modulators

TargetsInterleukin-1 betaTumor necrosis factor α

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesJuva Life Inc

China Registration ClassN/A

Active CompaniesJuva Life Inc

Inactive CompaniesN/A

Active IndicationsInflammation

Inactive IndicationsN/A

ATC CodeN/A